Sintesa

Sintesa Biotek is an Indonesian biotechnology company specializing in the development and manufacturing of molecular diagnostic solutions and life science research tools. As a subsidiary of the Sintesa Group, the company was established to bolster Indonesia's domestic healthcare infrastructure through the production of high-quality diagnostic kits. Sintesa Biotek gained significant recognition for its Sintesa-Gen line of PCR test kits, which were instrumental in the national response to the COVID-19 pandemic. Beyond infectious diseases, the company is expanding its portfolio to include diagnostic solutions for oncology and other chronic conditions. Their operations encompass research and development, manufacturing, and the distribution of laboratory reagents and equipment. The company plays a pivotal role in the regional biotechnology ecosystem by providing localized solutions for complex diagnostic needs.